Oncology Corporate Profile
"NewLink is a biopharmaceutical company focused on discovering, developing and commercializing novel immuno-oncology products to improve treatment options for patients with cancer. NewLink's portfolio includes biologic and small molecule immunotherapy product candidates intended to treat a wide range of oncology indications. NewLink's product candidates are designed to harness multiple components of the immune system to combat cancer without significant incremental toxicity, either as a monotherapy or in combination with other treatment regimens."
|Brand / Product||Class||Area of Study||Phase||Partnership|
|indoximod||IDO pathway inhibitor||Brain Metastases||II|
|indoximod||IDO pathway inhibitor||Breast cancer||II|
|Tergenpumatucel-L||immunotherapy||Non Small Cell Lung Cancer (NSCLC)||II|
|indoximod||IDO pathway inhibitor||Prostate cancer||II|
|HyperAcute_ Prostate||immunotherapy||Prostate cancer||I|
|HyperAcute_ Renal||immunotherapy||Renal cell carcinoma (RCC)||I|
|NL G919||IDO pathway inhibitor||Various cancer types||I|
View additional information on product candidates here »
3/20/2017 12:03 pm
3/17/2017 12:01 pm
[Accesswire] - Upcoming AWS Coverage on NewLink Genetics Post-Earnings Results LONDON, UK / ACCESSWIRE / March 17, 2017 / Active Wall St. blog coverage looks at the headline from PTC Therapeutics, Inc. (NASDAQ: PTCT ...
3/10/2017 06:00 pm
3/7/2017 06:02 pm
3/6/2017 07:01 pm
3/6/2017 12:00 pm
3/1/2017 10:03 pm
3/1/2017 10:01 pm
3/1/2017 10:00 pm
[GlobeNewswire] - AMES, Iowa, March 01, 2017-- NewLink Genetics Corporation, a biopharmaceutical company focused on bringing novel immuno-oncology therapies to patients with cancer, today reported that two abstracts on ...
2/28/2017 01:04 pm
2/28/2017 01:04 pm
2/28/2017 01:03 pm
2/28/2017 01:00 pm
[GlobeNewswire] - AMES, Iowa, Feb. 28, 2017-- NewLink Genetics Corporation, a biopharmaceutical company focused on bringing novel immuno-oncology therapies to patients with cancer, today reported consolidated financial ...
2/28/2017 12:00 pm
2/21/2017 03:00 pm
2/20/2017 12:00 pm
[GlobeNewswire] - AMES, Iowa, Feb. 20, 2017-- NewLink Genetics Corporation, today reported that it will release its fourth quarter and year end 2016 financial results on Tuesday, February 28, 2017. The company has scheduled ...
2/13/2017 10:01 pm
2/13/2017 12:00 pm
[GlobeNewswire] - AMES, Iowa, Feb. 13, 2017-- NewLink Genetics Corporation, a biopharmaceutical company focused on bringing novel immuno-oncology therapies to patients with cancer, today announced that it will participate ...
2/10/2017 08:02 am
1/18/2017 08:04 pm
[PR Newswire] - NEW YORK, Jan. 18, 2017 /PRNewswire/ -- DaVita Inc. (DVA) Lifshitz & Miller announces investigation on behalf of DVA investors concerning the receipt of subpoenas from federal prosecutors seeking "information ...
1/11/2017 04:01 pm
1/10/2017 12:01 pm
1/9/2017 09:04 pm
[Business Wire] - Newman Ferrara LLP announced today that the firm is conducting an investigation on behalf of shareholders of NewLink Genetics Corporation into potential breaches of fiduciary duty by the Company’s Board of Directors .
1/5/2017 10:01 pm
12/27/2016 06:03 pm